Rimonabant
id:
rimonabant-185-11101704
title:
Rimonabant
text:
Rimonabant is an anorectic antiobesity drug approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious psychiatric side effects; it was never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1 and was first-in-class for clinical development.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Rimonabant
date created:
2004-11-14T22:52:52Z
date modified:
2024-09-07T17:49:12Z
main entity:
{"identifier":"Q412529","url":"https://www.wikidata.org/entity/Q412529"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3c/Rimonabant.svg","width":572,"height":405}
fields total:
13
integrity:
16